login

The frequency and clinical course of cognitive impairment in patients with terminal cancer

CancerPublished 15 February 1997
José Pereira, John Hanson, Éduardo Bruera
Citations267
SJR quartileQ1
SJR score2.95
SNIP1.90

TL;DR

Cognitive screening should take place in patients with advanced cancer because cognitive failure is highly prevalent in this population, is reversible in a significant proportion of patients, and the presence of sustained cognitive impairment is a poor prognosticator for discharge.

Abstract

These data suggest that cognitive screening should take place in patients with advanced cancer because cognitive failure is highly prevalent in this population, is reversible in a significant proportion of patients, and the presence of sustained cognitive impairment is a poor prognosticator for discharge. However, these results need to be confirmed in prospective studies.

Keywords

Medicine